Literature DB >> 21854180

A turkey rhinotracheitis outbreak caused by the environmental spread of a vaccine-derived avian metapneumovirus.

Caterina Lupini1, Mattia Cecchinato, Enrico Ricchizzi, Clive J Naylor, Elena Catelli.   

Abstract

Avian metapneumovirus (aMPV) subtype A was isolated from 7-week-old turkeys showing respiratory disease typical of turkey rhinotracheitis. Comparison of the virus sequence with previously determined vaccine marker sequences showed that the virulent virus had originated from a licensed live subtype A aMPV vaccine. The vaccine had neither been in use on the farm within a period of at least 6 months nor had it been used on farms within a distance of approximately 5 km. Isolation of the virus and exposure to naive turkeys caused disease typical of a virulent aMPV field strain. The study shows that disease was caused by exposure to aMPV vaccine-derived virus that was present in the environment, and indicates that such virus is able to circulate for longer than was previously envisaged.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854180     DOI: 10.1080/03079457.2011.607428

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  7 in total

1.  First evidence of avian metapneumovirus subtype A infection in turkeys in Egypt.

Authors:  Abdel-Azeem Sayed Abdel-Azeem; Giovanni Franzo; Antonella Dalle Zotte; Michele Drigo; Elena Catelli; Caterina Lupini; Marco Martini; Mattia Cecchinato
Journal:  Trop Anim Health Prod       Date:  2014-04-23       Impact factor: 1.559

2.  Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Authors:  Jing Sun; Yongwei Wei; Abdul Rauf; Yu Zhang; Yuanmei Ma; Xiaodong Zhang; Konstantin Shilo; Qingzhong Yu; Y M Saif; Xingmeng Lu; Lian Yu; Jianrong Li
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Engineered Newcastle disease virus expressing the F and G proteins of AMPV-C confers protection against challenges in turkeys.

Authors:  Haixia Hu; Jason P Roth; Laszlo Zsak; Qingzhong Yu
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

4.  Avian Metapneumovirus subtype B around Europe: a phylodynamic reconstruction.

Authors:  Giovanni Franzo; Matteo Legnardi; Giulia Mescolini; Claudia Maria Tucciarone; Caterina Lupini; Giulia Quaglia; Elena Catelli; Mattia Cecchinato
Journal:  Vet Res       Date:  2020-07-08       Impact factor: 3.683

5.  Continued use of IBV 793B vaccine needs reassessment after its withdrawal led to the genotype's disappearance.

Authors:  Giovanni Franzo; Clive John Naylor; Caterina Lupini; Michele Drigo; Elena Catelli; Valeria Listorti; Patrizia Pesente; Davide Giovanardi; Emilio Morandini; Mattia Cecchinato
Journal:  Vaccine       Date:  2014-10-22       Impact factor: 3.641

6.  Efficacy of a novel avian metapneumovirus live vaccine candidate based on vaccination route and age.

Authors:  Ha-Na Youn; Jin-Yong Noh; Myeong-Seob Kim; Hyo-Sun Ju; Dam-Hee Park; Da-Ye Lee; Kyu-Jik Kim; Seong-Hye Go; Chang-Seon Song
Journal:  Poult Sci       Date:  2020-08-07       Impact factor: 3.352

7.  Molecular comparisons of full length metapneumovirus (MPV) genomes, including newly determined French AMPV-C and -D isolates, further supports possible subclassification within the MPV Genus.

Authors:  Paul A Brown; Evelyne Lemaitre; François-Xavier Briand; Céline Courtillon; Olivier Guionie; Chantal Allée; Didier Toquin; Marie-Hélène Bayon-Auboyer; Véronique Jestin; Nicolas Eterradossi
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.